News

Oct 14,2021

Immune-Onc Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating IO-108, a Novel Antagonist Antibody Targeting LILRB2 (ILT4), in Patients With Advanced Solid Tumors

read more >>

Aug 13,2021

Immune-Onc Therapeutics Announces FDA Clearance of IND Application to Initiate First-In-Human Trial of IO-108, a Novel Antagonist Antibody Targeting LILRB2, in Patients with Advanced Solid Tumors

read more >>

Aug 05,2021

Apexigen Receives Orphan Drug Designation from the FDA for Sotigalimab (APX005M) for the Treatment of Soft Tissue Sarcoma

read more >>

Jul 23,2021

Cytek Biosciences Announces Pricing of Its Initial Public Offering

read more >>

Jul 19,2021

Cell analysis instruments provider Cytek BioSciences sets terms for $248 million IPO

read more >>

Jul 15,2021

Aravive Achieves Second Development Milestone from 3D Medicines

read more >>

Jul 01,2021

Twist Bioscience Acquires NGS Library Preparation Maker iGenomX

read more >>

Jun 16,2021

KBP Biosciences Announces A Greater Than 10 mm Hg Systolic Blood Pressure Reduction in The BLOCK-CKD Phase 2b Study of KBP-5074 in Advanced Chronic Kidney Disease Patients with Uncontrolled Hypertension as Published in Hypertension

read more >>